From target identification and validation to preclinical candidate delivery, IRBM provides the full spectrum of drug discovery capabilities across small molecules, peptides, and antibodies.
Whether you are a biotech or pharma team advancing a novel program end-to-end or seeking specialized expertise to accelerate a critical phase of your pipeline, IRBM operates as a true extension of your research team.
Our factsheet outlines how our integrated, multi-modality approach consistently transforms complex biological challenges into development-ready preclinical assets.